LIXT: Lixte Biotechnology Holdings Inc

LIXT新闻

• 13:13 LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary
• 13:17 LIXTE expands clinical trial for ovarian cancer treatment
• 21:57 Lixte生物科技在430万美元直接发行后股价下跌
• 21:55 斯巴达资本担任Lixte 430万美元融资的配售代理
• 21:53 Lixte Biotechnology stock falls after $4.3 million direct offering
• 21:53 Spartan Capital acts as placement agent in Lixte’s $4.3 million offering
• 15:39 Lixte生物科技股价在430万美元直接融资后下跌
• 15:36 Lixte Biotechnology stock falls after $4.3 million direct offering
• 14:35 Lixte Biotechnology raises $4.3 million in registered direct offering
• 20:04 Lixte生物科技股东批准董事会提名人选和股票计划修订案
• 20:03 Lixte Biotechnology shareholders approve board nominees and stock plan amendment
• 15:27 Lixte生物科技股价在收购英国Liora后下跌
• 15:27 Lixte Biotechnology stock falls after acquiring UK-based Liora
• 13:55 LIXTE生物科技收购英国质子疗法开发商Liora
• 13:53 LIXTE Biotechnology acquires UK-based proton therapy developer Liora
• 23:35 Earlyworks股东否决收购发行股票提案，批准新董事和权证
• 23:35 Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants
• 21:47 Lixte生物科技更新领导层并多元化资产